Looking at drug resistance mechanisms for microtubule interacting drugs: does TUBB3 work?
about
Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive CancersNew insights into mechanisms of resistance to microtubule inhibitorsIdentification of the first inhibitor of the GBP1:PIM1 interaction. Implications for the development of a new class of anticancer agents against paclitaxel resistant cancer cells.Ixabepilone development across the breast cancer continuum: a paradigm shift.Combining emerging agents in advanced breast cancerBilateral breast cancer following augmentation mammaplasty with polyacrylamide hydrogel injection: A case reportDistinct alpha- and beta-tubulin isotypes are required for the positioning, differentiation and survival of neurons: new support for the 'multi-tubulin' hypothesis.Microtubule-severing ATPase spastin in glioblastoma: increased expression in human glioblastoma cell lines and inverse roles in cell motility and proliferationCurrent status and implications of microRNAs in ovarian cancer diagnosis and therapy.Tubulin-β-III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones.Microtubule stabilising agents for cancer chemotherapy.Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. Class III beta-tubulin.Class III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carboplatin/paclitaxelMolecular epigenetics in the management of ovarian cancer: are we investigating a rational clinical promise?Class III b-tubulin overexpression in gynecologic tumors: implications for the choice of microtubule targeted agents?Effect of CH-35, a novel anti-tumor colchicine analogue, on breast cancer cells overexpressing the βIII isotype of tubulin.Use of Integrated Computational Approaches in the Search for New Therapeutic Agents.Longitudinal assessment of TUBB3 expression in non-small cell lung cancer patients.Quantitative analysis of the effect of tubulin isotype expression on sensitivity of cancer cell lines to a set of novel colchicine derivatives.The efficacy and safety of gemcitabine, cisplatin, prednisone, thalidomide versus CHOP in patients with newly diagnosed peripheral T-cell lymphoma with analysis of biomarkers.
P2860
Q21296833-B0F3C703-E141-4514-97FC-B903737995CAQ24633853-5D51EA6C-019F-49C6-8F06-C5983C9ECAD6Q34313834-E720F484-358D-4936-863A-318DF81C35B0Q34417996-AFDE863C-42C6-42C4-B0DA-D82AA0C5DEF8Q35584962-46C78F37-F061-4564-8AAF-148E0166ABDDQ35758146-542FEFAA-F326-48B1-B3DB-389E7DB3F572Q35869187-C5B70C66-2B9A-4692-8CB5-5864CA1181D2Q36104749-F50318B8-E14A-466C-8D3A-EA3E6B696447Q36517492-22A4292D-2B45-484D-B5DA-AB6A1F3096E7Q36980135-64AE9358-2923-4D09-9421-AFF6E025FDD8Q37481355-31CB1885-6D92-4220-B9C4-059F6C6F3BE2Q37570220-79A83A57-4A35-468A-AEFC-9E2DDBD5A080Q37625835-0AE74A80-0225-4BF9-BF18-250C2CAC10F0Q37702543-2B738265-8F2C-4D56-98E6-1BCCB5D02921Q38069185-9D58C543-8A69-4334-B48F-517673162BCDQ38810389-E1E8FE57-706A-45FE-A844-D419C97BF922Q38933291-D992EBF1-2EC0-4DA3-9531-9BD9473A9BECQ39316677-6B68A548-9869-405F-BBCD-A59681244FD1Q39699060-8A06A5A9-9191-47A6-8CCA-5BB73E837A8DQ48301800-6CDA9977-05C8-4952-B960-D54FFE20FFD7
P2860
Looking at drug resistance mechanisms for microtubule interacting drugs: does TUBB3 work?
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Looking at drug resistance mechanisms for microtubule interacting drugs: does TUBB3 work?
@ast
Looking at drug resistance mechanisms for microtubule interacting drugs: does TUBB3 work?
@en
Looking at drug resistance mechanisms for microtubule interacting drugs: does TUBB3 work?
@nl
type
label
Looking at drug resistance mechanisms for microtubule interacting drugs: does TUBB3 work?
@ast
Looking at drug resistance mechanisms for microtubule interacting drugs: does TUBB3 work?
@en
Looking at drug resistance mechanisms for microtubule interacting drugs: does TUBB3 work?
@nl
prefLabel
Looking at drug resistance mechanisms for microtubule interacting drugs: does TUBB3 work?
@ast
Looking at drug resistance mechanisms for microtubule interacting drugs: does TUBB3 work?
@en
Looking at drug resistance mechanisms for microtubule interacting drugs: does TUBB3 work?
@nl
P50
P1476
Looking at drug resistance mechanisms for microtubule interacting drugs: does TUBB3 work?
@en
P304
P356
10.2174/156800907783220453
P407
P50
P577
2007-12-01T00:00:00Z